HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alessandro Leal Selected Research
Alessandro Leal Research Topics
Disease
14
Neoplasms (Cancer)
11/2023 - 08/2017
7
Lung Neoplasms (Lung Cancer)
11/2023 - 01/2019
5
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 01/2019
3
Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 08/2017
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021
1
Stomach Neoplasms (Stomach Cancer)
01/2020
1
COVID-19
01/2020
1
Glioblastoma (Glioblastoma Multiforme)
01/2020
1
Carcinogenesis
01/2020
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2019
1
Residual Neoplasm
01/2019
Drug/Important Bio-Agent (IBA)
6
Circulating Tumor DNA
IBA
01/2023 - 08/2017
5
Cell-Free Nucleic Acids
IBA
01/2023 - 01/2019
4
Biomarkers (Surrogate Marker)
IBA
11/2023 - 01/2020
2
DNA (Deoxyribonucleic Acid)
IBA
01/2023 - 01/2020
2
Tyrosine Kinase Inhibitors
IBA
12/2019 - 01/2019
1
Transcription Factors (Transcription Factor)
IBA
01/2021
1
Bevacizumab (Avastin)
FDA Link
01/2021
1
ErbB Receptors (EGF Receptor)
IBA
12/2020
1
Antibodies
IBA
12/2020
1
Chromatin
IBA
01/2020
1
Nucleosomes (Nucleosome)
IBA
01/2020
1
Sunitinib (Sutent)
FDA Link
12/2019
1
Imatinib Mesylate (Gleevec)
FDA Link
12/2019
1
regorafenib
IBA
12/2019
1
Therapeutic Uses
IBA
01/2019
1
Immune Checkpoint Inhibitors
IBA
01/2019
Therapy/Procedure
7
Therapeutics
11/2023 - 01/2019
2
Immunotherapy
11/2023 - 06/2023
2
Drug Therapy (Chemotherapy)
01/2021 - 01/2020
1
Length of Stay
01/2020
1
Radiotherapy
01/2020